利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

8 条记录 (耗时 0.042 秒)

    Pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases
    1.
    发明申请
    Pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases 有权
    用于治疗心血管和脑血管疾病的药物组合物

    公开(公告)号：US20070053999A1

    公开(公告)日：2007-03-08

    申请号：US10572083

    申请日：2004-09-23

    申请人： Feng Wei ,  Dekun Li ,  Chongnian Luo ,  Hongshui Yue ,  Qingchuang Chen ,  Zhijuan Huang

    发明人： Feng Wei ,  Dekun Li ,  Chongnian Luo ,  Hongshui Yue ,  Qingchuang Chen ,  Zhijuan Huang

    IPC分类号： A61K36/537 ,  A61K36/254 ,  A61K36/258 ,  A61K36/48

    CPC分类号： A61K36/258 ,  A61K31/7048 ,  A61K36/00 ,  A61K36/481 ,  A61K36/537 ,  A61K2300/00

    摘要： The present invention discloses a pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases which comprises Radix Salviae Miltiorrhizae extract 5.0%-70.0%, Radix Notoginseng extract 10.0%-85.0%, Radix Astragali extract 5.0%-70.0%, and Bomeol or oil of Lignum Dalbergiae Odoriferae 1.0%-15.0%. The composition is active against cerebral ischemia and myocardial ischemia. The effects are superior to total phenic acid of Radix Salviae Miltiorrhizae or total saponin of Radix Notoginseng respectively, or the combination thereof. The composition of the invention can provide various kinds of preparations by the addition of various accessories. Thus the invention provides a more effective and convenient composition of TCM effective sections and its preparations.

    摘要翻译： 本发明公开了一种用于治疗心血管和脑血管疾病的药物组合物，其含有百草丹提取物5.0％-70.0％，三七提取物10.0％-85.0％，黄芪提取物5.0％-70.0％，和Bomeol或 枸杞1.0％-15.0％。 该组合物对脑缺血和心肌缺血具有活性。 其效果优于三七总皂甙或总皂甙或其组合。 本发明的组合物可以通过添加各种附件来提供各种制剂。 因此，本发明提供了一种更有效，更方便的中药有效切片及其制备方法。

    Pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases
    2.
    发明授权
    Pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases 有权
    用于治疗心血管和脑血管疾病的药物组合物

    公开(公告)号：US07438935B2

    公开(公告)日：2008-10-21

    申请号：US10572083

    申请日：2004-09-23

    申请人： Feng Wei ,  Dekun Li ,  Chongnian Luo ,  Hongshui Yue ,  Qingchuang Chen ,  Zhijuan Huang

    发明人： Feng Wei ,  Dekun Li ,  Chongnian Luo ,  Hongshui Yue ,  Qingchuang Chen ,  Zhijuan Huang

    IPC分类号： A61K36/25 ,  A61K36/537 ,  A61K36/00

    CPC分类号： A61K36/258 ,  A61K31/7048 ,  A61K36/00 ,  A61K36/481 ,  A61K36/537 ,  A61K2300/00

    摘要： The present invention discloses a pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases which comprises Radix Salviae Miltiorrhizae extract 5.0%-70.0%, Radix Notoginseng extract 10.0%-85.0%, Radix Astragali extract 5.0%-70.0%, and Bomeol or oil of Lignum Dalbergiae Odoriferae 1.0%-15.0%. The composition is active against cerebral ischemia and myocardial ischemia. The effects are superior to total phenic acid of Radix Salviae Miltiorrhizae or total saponin of Radix Notoginseng respectively, or the combination thereof. The composition of the invention can provide various kinds of preparations by the addition of various accessories. Thus the invention provides a more effective and convenient composition of TCM effective sections and its preparations.

    摘要翻译： 本发明公开了一种用于治疗心血管和脑血管疾病的药物组合物，其含有百草丹提取物5.0％-70.0％，三七提取物10.0％-85.0％，黄芪提取物5.0％-70.0％，和Bomeol或 枸杞1.0％-15.0％。 该组合物对脑缺血和心肌缺血具有活性。 其效果优于三七总皂甙或总皂甙或其组合。 本发明的组合物可以通过添加各种附件来提供各种制剂。 因此，本发明提供了一种更有效，更方便的中药有效切片及其制备方法。

    Preparation and application of transhintotalphenolic acid
    5.
    发明授权
    Preparation and application of transhintotalphenolic acid 有权
    透皮酚酸的制备与应用

    公开(公告)号：US07641922B2

    公开(公告)日：2010-01-05

    申请号：US10515963

    申请日：2003-05-21

    申请人： Feng Wei ,  Hongshui Yue ,  Dekun Li ,  Jiangxiao Sun ,  Zhengliang Ye ,  Xu Li

    发明人： Feng Wei ,  Hongshui Yue ,  Dekun Li ,  Jiangxiao Sun ,  Zhengliang Ye ,  Xu Li

    IPC分类号： A61K36/00 ,  A61K36/537

    CPC分类号： A61K31/34 ,  A61K31/19 ,  C07D307/84

    摘要： A process for preparing tanshintotalphenolic acid and the use of the product are disclosed. The process comprises: tanshin is hot-extracted with water, the extract is separated and refined by polyamide column and macroporous adsorption resin column, and lyophilized to obtain tanshintotalphenolic acid. The yield of the final end product is more than 4 percent based on the amount of crude drug and the content of totalphenolic acid is more than 80 percent. The tanshintotalphenolic acid obtained can be used as the medicine for preventing and treating cerebrovascular and cardiovascular diseases and so on.

    摘要翻译： 公开了制备丹参酚酸的方法及其用途。 该方法包括：用水提取丹参，用聚酰胺柱和大孔吸附树脂柱分离精制提取物，冻干得到丹参酚酸。 最终产品的产率基于生药量大于4％，总酚酸含量大于80％。 获得的丹参酚酸可用作预防和治疗脑血管和心血管疾病的药物等。